Last Updated: 2004-11-15 16:20:34 -0400 (Reuters Health)
WASHINGTON (Reuters) - Researchers who found a genetic pattern that predicts who will be helped by a revolutionary new lung cancer drug said on Monday they were looking for patients to help them confirm their findings.
The team at Massachusetts General Hospital Cancer Center in Boston needs to find patients with advanced non-small-cell lung cancer to see if DNA patterns indeed show who will be helped by the drug, called Iressa.
